Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website: www.arraybiopharma.com.
| Event: |
Piper Jaffray Annual Healthcare Conference |
| Date: |
Tuesday, November 29, 2016 |
| Time: |
12:35 p.m. Eastern Standard Time |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.
| CONTACT: |
Tricia Haugeto |
| Array BioPharma Inc. |
|
| 303-386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article